Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13)

Yubo Sun, Jamie M. Cheung, Joanne Martel-Pelletier, Jean P. Pelletier, Leonor Wenger, Roy D Altman, David S. Howell, Herman S Cheung

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Matrix metalloproteinases (MMPs) are a family of secreted or transmembrane proteins that can degrade all the proteins of the extracellular matrix and have been implicated in many abnormal physiological conditions including arthritis and cancer metastasis. Recently we have shown for the first time that the human MMP-1 gene is a p53 target gene subject to repression by wild type p53 (Sun, Y., Sun, Y. I., Wenger, L., Rutter, J. L., Brinckerhoff, C. E., and Cheung, H. S. (1999) J. Biol. Chem. 274, 11535- 11540). Here, we report that cotransfection of fibroblast-like synoviocytes with p53 expression and hMMP13CAT reporter plasmids revealed that (i) hMMP13, another member of the human MMP family, was down-regulated by wild type p53, whereas all six of the p53 mutants tested lost the wild type p53 repressor activity in fibroblast-like synoviocytes; (ii) this repression of hMMP-13 gene expression by wild type p53 could be reversed by overexpression of p53 mutants p53-143A, p53-248W, p53-273H, and p53-281G; (iii) the dominant effect of p53 mutants over wild type p53 appears to be a promoter- and mutant- specific effect. An intriguing finding was that p53 mutant p53-281G could conversely stimulate the promoter activity of hMMP13 up to 2-4-fold and that it was dominant over wild type p53. Northern analysis confirmed these findings. Although the significance of these findings is currently unknown, they suggest that in addition to the effect of cytokines activation, the gene expression of hMMP13 could be dysregulated during the disease progression of rheumatoid arthritis (or cancer) associated with p53 inactivation. Since hMMP13 is 5-10 times as active as hMMP1 in its ability to digest type II collagen, the dysregulation or up-modulation of MMP13 gene expression due to the inactivation of p53 may contribute to the joint degeneration in rheumatoid arthritis.

Original languageEnglish
Pages (from-to)11327-11332
Number of pages6
JournalJournal of Biological Chemistry
Volume275
Issue number15
DOIs
StatePublished - Apr 14 2000

Fingerprint

Matrix Metalloproteinase 13
Gene expression
Fibroblasts
Matrix Metalloproteinases
Gene Expression
Rheumatoid Arthritis
Genes
Collagen Type II
Extracellular Matrix Proteins
p53 Genes
Arthritis
Disease Progression
Neoplasms
Plasmids
Joints
Chemical activation
Modulation
Cytokines
Neoplasm Metastasis
Proteins

ASJC Scopus subject areas

  • Biochemistry

Cite this

Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13). / Sun, Yubo; Cheung, Jamie M.; Martel-Pelletier, Joanne; Pelletier, Jean P.; Wenger, Leonor; Altman, Roy D; Howell, David S.; Cheung, Herman S.

In: Journal of Biological Chemistry, Vol. 275, No. 15, 14.04.2000, p. 11327-11332.

Research output: Contribution to journalArticle

Sun, Y, Cheung, JM, Martel-Pelletier, J, Pelletier, JP, Wenger, L, Altman, RD, Howell, DS & Cheung, HS 2000, 'Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13)', Journal of Biological Chemistry, vol. 275, no. 15, pp. 11327-11332. https://doi.org/10.1074/jbc.275.15.11327
Sun Y, Cheung JM, Martel-Pelletier J, Pelletier JP, Wenger L, Altman RD et al. Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13). Journal of Biological Chemistry. 2000 Apr 14;275(15):11327-11332. https://doi.org/10.1074/jbc.275.15.11327
Sun, Yubo ; Cheung, Jamie M. ; Martel-Pelletier, Joanne ; Pelletier, Jean P. ; Wenger, Leonor ; Altman, Roy D ; Howell, David S. ; Cheung, Herman S. / Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13). In: Journal of Biological Chemistry. 2000 ; Vol. 275, No. 15. pp. 11327-11332.
@article{b32f9dd658674bc1b5c3edb4effccb73,
title = "Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13)",
abstract = "Matrix metalloproteinases (MMPs) are a family of secreted or transmembrane proteins that can degrade all the proteins of the extracellular matrix and have been implicated in many abnormal physiological conditions including arthritis and cancer metastasis. Recently we have shown for the first time that the human MMP-1 gene is a p53 target gene subject to repression by wild type p53 (Sun, Y., Sun, Y. I., Wenger, L., Rutter, J. L., Brinckerhoff, C. E., and Cheung, H. S. (1999) J. Biol. Chem. 274, 11535- 11540). Here, we report that cotransfection of fibroblast-like synoviocytes with p53 expression and hMMP13CAT reporter plasmids revealed that (i) hMMP13, another member of the human MMP family, was down-regulated by wild type p53, whereas all six of the p53 mutants tested lost the wild type p53 repressor activity in fibroblast-like synoviocytes; (ii) this repression of hMMP-13 gene expression by wild type p53 could be reversed by overexpression of p53 mutants p53-143A, p53-248W, p53-273H, and p53-281G; (iii) the dominant effect of p53 mutants over wild type p53 appears to be a promoter- and mutant- specific effect. An intriguing finding was that p53 mutant p53-281G could conversely stimulate the promoter activity of hMMP13 up to 2-4-fold and that it was dominant over wild type p53. Northern analysis confirmed these findings. Although the significance of these findings is currently unknown, they suggest that in addition to the effect of cytokines activation, the gene expression of hMMP13 could be dysregulated during the disease progression of rheumatoid arthritis (or cancer) associated with p53 inactivation. Since hMMP13 is 5-10 times as active as hMMP1 in its ability to digest type II collagen, the dysregulation or up-modulation of MMP13 gene expression due to the inactivation of p53 may contribute to the joint degeneration in rheumatoid arthritis.",
author = "Yubo Sun and Cheung, {Jamie M.} and Joanne Martel-Pelletier and Pelletier, {Jean P.} and Leonor Wenger and Altman, {Roy D} and Howell, {David S.} and Cheung, {Herman S}",
year = "2000",
month = "4",
day = "14",
doi = "10.1074/jbc.275.15.11327",
language = "English",
volume = "275",
pages = "11327--11332",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "15",

}

TY - JOUR

T1 - Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13)

AU - Sun, Yubo

AU - Cheung, Jamie M.

AU - Martel-Pelletier, Joanne

AU - Pelletier, Jean P.

AU - Wenger, Leonor

AU - Altman, Roy D

AU - Howell, David S.

AU - Cheung, Herman S

PY - 2000/4/14

Y1 - 2000/4/14

N2 - Matrix metalloproteinases (MMPs) are a family of secreted or transmembrane proteins that can degrade all the proteins of the extracellular matrix and have been implicated in many abnormal physiological conditions including arthritis and cancer metastasis. Recently we have shown for the first time that the human MMP-1 gene is a p53 target gene subject to repression by wild type p53 (Sun, Y., Sun, Y. I., Wenger, L., Rutter, J. L., Brinckerhoff, C. E., and Cheung, H. S. (1999) J. Biol. Chem. 274, 11535- 11540). Here, we report that cotransfection of fibroblast-like synoviocytes with p53 expression and hMMP13CAT reporter plasmids revealed that (i) hMMP13, another member of the human MMP family, was down-regulated by wild type p53, whereas all six of the p53 mutants tested lost the wild type p53 repressor activity in fibroblast-like synoviocytes; (ii) this repression of hMMP-13 gene expression by wild type p53 could be reversed by overexpression of p53 mutants p53-143A, p53-248W, p53-273H, and p53-281G; (iii) the dominant effect of p53 mutants over wild type p53 appears to be a promoter- and mutant- specific effect. An intriguing finding was that p53 mutant p53-281G could conversely stimulate the promoter activity of hMMP13 up to 2-4-fold and that it was dominant over wild type p53. Northern analysis confirmed these findings. Although the significance of these findings is currently unknown, they suggest that in addition to the effect of cytokines activation, the gene expression of hMMP13 could be dysregulated during the disease progression of rheumatoid arthritis (or cancer) associated with p53 inactivation. Since hMMP13 is 5-10 times as active as hMMP1 in its ability to digest type II collagen, the dysregulation or up-modulation of MMP13 gene expression due to the inactivation of p53 may contribute to the joint degeneration in rheumatoid arthritis.

AB - Matrix metalloproteinases (MMPs) are a family of secreted or transmembrane proteins that can degrade all the proteins of the extracellular matrix and have been implicated in many abnormal physiological conditions including arthritis and cancer metastasis. Recently we have shown for the first time that the human MMP-1 gene is a p53 target gene subject to repression by wild type p53 (Sun, Y., Sun, Y. I., Wenger, L., Rutter, J. L., Brinckerhoff, C. E., and Cheung, H. S. (1999) J. Biol. Chem. 274, 11535- 11540). Here, we report that cotransfection of fibroblast-like synoviocytes with p53 expression and hMMP13CAT reporter plasmids revealed that (i) hMMP13, another member of the human MMP family, was down-regulated by wild type p53, whereas all six of the p53 mutants tested lost the wild type p53 repressor activity in fibroblast-like synoviocytes; (ii) this repression of hMMP-13 gene expression by wild type p53 could be reversed by overexpression of p53 mutants p53-143A, p53-248W, p53-273H, and p53-281G; (iii) the dominant effect of p53 mutants over wild type p53 appears to be a promoter- and mutant- specific effect. An intriguing finding was that p53 mutant p53-281G could conversely stimulate the promoter activity of hMMP13 up to 2-4-fold and that it was dominant over wild type p53. Northern analysis confirmed these findings. Although the significance of these findings is currently unknown, they suggest that in addition to the effect of cytokines activation, the gene expression of hMMP13 could be dysregulated during the disease progression of rheumatoid arthritis (or cancer) associated with p53 inactivation. Since hMMP13 is 5-10 times as active as hMMP1 in its ability to digest type II collagen, the dysregulation or up-modulation of MMP13 gene expression due to the inactivation of p53 may contribute to the joint degeneration in rheumatoid arthritis.

UR - http://www.scopus.com/inward/record.url?scp=0034646643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034646643&partnerID=8YFLogxK

U2 - 10.1074/jbc.275.15.11327

DO - 10.1074/jbc.275.15.11327

M3 - Article

C2 - 10753945

AN - SCOPUS:0034646643

VL - 275

SP - 11327

EP - 11332

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 15

ER -